Dr Brigitte Sigal has been a pathologist at Institut Curie since 1983, with specific expertise in breast pathology. For 12 years she coordinated the multidisciplinary breast pathology group at Institut Curie (Groupe Sein) and was director of the Senology division for 3 years.
She as President of the scientific advisory board of the breast cancer screening network in the Paris region (GYNECOMED).
She has published over 190 articles in scientific journals. She has taught at several breast pathology courses in France and abroad.
Dr Brigitte Sigal is coordinating the clinical and translational research project into understanding the molecular mechanisms of the initial metastatic relapse of breast cancer in order to improve patient treatment.